Facebook
Twitter
Telegram
Report an ErrorWindtree Therapeutics Financial Ratios 2011-2024 | WINT
Annual Financial Ratios Windtree Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.1 | -0.1 | -0.0 | -2.7 | -5.0 | -0.9 | -0.2 | -0.3 | -0.3 | -8.1 | -8.4 | -7.0 | -7.0 |
P/S |
- | - | - | - | 695.4 | 10.8 | 3.1 | 5.4 | 16.8 | 125.2 | 973.5 | 1305.4 | 253.7 |
EPS |
-5.2 | -62.2 | -136.6 | -2.1 | -2.5 | -7.7 | -24.1 | -4.7 | -8.0 | -7.3 | -0.8 | -0.9 | -0.9 |
EV (Enterprise Value) |
26.4 M | 24.9 M | 11.1 M | 114 M | 159 M | 59.5 M | 30 M | 43.9 M | 14 M | 338 M | 324 M | 246 M | 149 M |
EBITDA per Share |
-5.29 | -64.8 | -156 | -2.06 | -2.42 | -12.9 | -48.2 | -272 | -438 | -140 | -219 | -262 | -291 |
EV/EBITDA |
-0.5 | -2.3 | -5.1 | -1.6 | -1.1 | -0.8 | -0.1 | -7.8 | -7.1 | -6.4 | -5.9 | ||
PEG |
-0.0 | -0.0 | -0.0 | -0.16 | -0.06 | -0.01 | -0.0 | -0.01 | 0.0 | -0.22 | -0.55 | 4.12 | -0.15 |
P/B |
0.5 | 0.3 | 0.0 | 1.3 | 1.8 | 0.3 | -0.2 | -0.4 | 2.0 | 18.5 | 6.5 | 14.8 | 116.4 |
P/CF |
-0.1 | -0.2 | -0.0 | -3.4 | -5.5 | -1.2 | -0.2 | -0.3 | -0.5 | -8.5 | -9.2 | -7.8 | -6.5 |
ROE % |
-598.38 | -391.61 | -161.50 | -46.82 | -36.67 | -30.15 | 77.12 | 136.98 | -667.43 | -229.48 | -77.30 | -211.41 | -1659.02 |
ROA % |
-62.61 | -103.30 | -90.44 | -28.85 | -23.09 | -17.20 | -551.12 | -407.16 | -124.32 | -92.76 | -50.64 | -124.82 | -157.67 |
ROCE % |
-607.40 | -412.83 | -184.52 | -28.40 | -24.01 | -19.78 | 198.79 | 1030.23 | -154.89 | -109.04 | -57.51 | -207.80 | -1114.09 |
Current Ratio |
1.1 | 1.4 | 2.3 | 3.0 | 3.1 | 1.2 | 0.2 | 0.5 | 3.7 | 5.8 | 7.3 | 2.4 | 1.0 |
DSO |
- | - | - | - | - | - | - | - | - | - | 93.6 | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | 70.2 | 44.2 | - |
DPO |
- | - | - | - | - | - | - | - | 145.0 | - | 982.7 | 265.5 | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | 163.8 | 44.2 | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | -145.0 | - | -818.9 | -221.2 | - |
All numbers in USD currency
Quarterly Financial Ratios Windtree Therapeutics
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
21.98 | - | -0.86 | -1.64 | -85.65 | - | -6.51 | -29.68 | -14.36 | - | -0.31 | -1.42 | -0.51 | - | -0.54 | -0.63 | -0.48 | -0.21 | -0.66 | -0.6 | -0.61 | -3.24 | -1.04 | -0.81 | -1.4 | 1.03 | -10.53 | -14.37 | -27.4 | -0.77 | -1 | -1.29 | -1.7 | -1.26 | -2.8 | -1.82 | -1.96 | -1.68 | -1.82 | -1.68 | -1.96 | -0.16 | -0.22 | -0.18 | -0.29 | -0.16 | -0.31 | -0.16 | -0.37 | -0.18 | -0.2 | -0.34 | -0.21 |
EBITDA per Share |
-9.43 | - | - | - | -86.8 | - | -6.65 | -29.2 | -13.9 | - | -0.3 | -1.72 | -0.51 | - | -0.52 | -0.52 | -0.49 | -0.13 | -0.65 | -0.59 | -0.62 | -0.67 | -0.89 | -0.79 | -1.49 | -1.45 | -6.58 | -11.9 | -17.9 | -0.75 | -0.9 | -1.2 | -1.69 | -1.22 | -1.04 | -1.61 | -1.76 | -1.84 | -1.6 | -1.74 | -1.75 | -0.14 | -0.19 | -0.21 | -0.28 | -0.29 | -0.21 | -0.19 | -0.23 | -243 | -216 | -239 | -317 |
ROE % |
-108.87 | -174.50 | -197.78 | -161.94 | -195.34 | -136.97 | -153.34 | -146.43 | -122.00 | -92.03 | -105.00 | -101.60 | -49.47 | -36.11 | -45.95 | -42.49 | -37.34 | -36.67 | -40.10 | -36.35 | -32.24 | -30.15 | -27.21 | 1.31 | 34.02 | 77.12 | 110.35 | 116.61 | 125.23 | 136.98 | -8.22 | -298.01 | -471.88 | -667.43 | -600.53 | -398.73 | -317.05 | -229.48 | -194.14 | -156.05 | -115.47 | -77.29 | -95.85 | -150.55 | -176.24 | -211.38 | -513.04 | -813.31 | -1411.80 | -1658.62 | -375.87 | -638.92 | -303.56 |
ROA % |
-6.87 | -40.22 | -48.66 | -44.82 | -62.00 | -54.00 | -63.68 | -64.93 | -72.62 | -57.42 | -65.41 | -63.72 | -31.04 | -22.25 | -28.44 | -26.44 | -23.39 | -23.09 | -24.47 | -21.77 | -18.91 | -17.20 | 64.26 | -95.07 | -294.25 | -551.12 | -693.08 | -616.68 | -524.48 | -407.16 | -361.87 | -324.22 | -240.20 | -124.32 | -123.93 | -99.20 | -96.04 | -92.76 | -83.50 | -73.34 | -60.64 | -50.62 | -60.25 | -91.14 | -105.32 | -124.62 | -134.14 | -125.23 | -162.00 | -157.35 | -35.66 | -60.61 | -28.80 |
ROCE % |
-212.13 | -180.52 | -207.21 | -171.24 | -204.37 | -142.05 | -158.28 | -147.82 | -136.38 | -106.07 | -118.59 | -114.87 | -46.38 | -33.58 | -39.66 | -36.73 | -33.97 | -33.22 | -34.26 | -29.76 | -25.55 | -23.78 | -2.03 | 23.10 | 53.23 | 94.26 | 101.73 | 108.51 | 117.50 | 131.93 | -8.48 | -137.45 | -298.37 | -481.90 | -422.05 | -373.69 | -304.42 | -225.31 | -184.39 | -149.08 | -110.57 | -76.08 | -128.92 | -167.07 | -198.53 | -214.24 | -610.86 | -1042.36 | -1497.16 | -1939.24 | -488.13 | -504.75 | -479.35 |
Current Ratio |
2.0 | 1.1 | 1.3 | 1.4 | 1.2 | 1.4 | 1.6 | 1.6 | 2.1 | 2.3 | 2.5 | 2.7 | 3.1 | 2.6 | 2.6 | 2.6 | 2.6 | 2.7 | 2.7 | 2.7 | 2.7 | 2.3 | 2.3 | 2.3 | 2.3 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 | 1.2 | 1.2 | 1.2 | 1.2 | 1.7 | 1.7 | 1.7 | 1.7 | 2.9 | 2.9 | 2.9 | 2.9 | 2.4 | 2.4 | 2.4 | 2.4 | 1.1 | 1.1 | 1.1 | 1.1 |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.8 | 5.5 | 1.7 | 98.6 | - | 101.9 | 33.6 | 42.5 | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.8 | 5.5 | 1.7 | 98.6 | - | 101.9 | 33.6 | 42.5 | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.8 | 5.5 | 1.7 | 98.6 | - | 101.9 | 33.6 | 42.5 | - | - | - | - | - | - | - | - |
All numbers in USD currency